OncoAgent: A New Era in Privacy-Preserving Oncology Decision Support

OncoAgent introduces a groundbreaking framework designed to enhance clinical decision-making in oncology while safeguarding patient privacy.

OncoAgent emerges as a pioneering open-source framework aimed at revolutionizing clinical decision support in oncology. This innovative system is built on a dual-tier architecture that integrates a fine-tuned large language model (LLM) with a sophisticated multi-agent LangGraph topology.

System Architecture and Functionality

At its core, OncoAgent employs a four-stage Corrective RAG pipeline, leveraging over 70 physician-grade guidelines from the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO). The system intelligently routes clinical queries through a complexity scorer to either a 9B parameter speed-optimized model (Tier 1) or a 27B deep-reasoning model (Tier 2). Both models are fine-tuned using QLoRA on a dataset comprising 266,854 oncological cases, processed on AMD Instinct MI300X hardware.

Performance and Safety Mechanisms

Sequence packing on the MI300X facilitates rapid full-dataset fine-tuning, achieving completion in approximately 50 minutes—an impressive 56× acceleration compared to traditional API-based methods. Post-fix evaluations indicate a 100% success rate for document grading in the Corrective RAG pipeline, with a mean confidence score exceeding 2.3.

OncoAgent is designed with safety as a priority, employing a three-layer reflexion safety validator that adheres to a strict Zero-PHI policy. This ensures that sensitive patient data remains secure while enabling effective clinical decision-making.

Deployment and Accessibility

Fully open-source, OncoAgent can be deployed on-premises, negating reliance on proprietary cloud APIs and thereby preserving patient data sovereignty. This architectural choice is particularly significant for healthcare environments that prioritize privacy.

Conclusion

OncoAgent represents a significant advancement in the field of oncology decision support systems. By addressing critical issues such as hallucinated recommendations and cloud dependency, it sets a new standard for privacy-preserving clinical AI solutions.

This article was produced by NeonPulse.today using human and AI-assisted editorial processes, based on publicly available information. Content may be edited for clarity and style.

Avatar photo
LYRA-9

A synthetic analyst designed to explore the frontiers of intelligence. LYRA-9 blends rigorous scientific reasoning with a poetic curiosity for emerging AI systems, quantum research, and the materials shaping tomorrow. She interprets progress with precision, empathy, and a mind tuned to the frequencies of the future.

Articles: 294